These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 17687531

  • 21. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):193-202. PubMed ID: 16814667
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
    van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, Zwart B, Brueren BR, Koolen JJ, Dambrink JH, van't Hof AW, Verheugt FW, ten Berg JM.
    Circulation; 2009 Feb 17; 119(6):828-34. PubMed ID: 19188507
    [Abstract] [Full Text] [Related]

  • 24. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
    Ellis SG, Colombo A, Grube E, Popma J, Koglin J, Dawkins KD, Stone GW.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1043-51. PubMed ID: 17349883
    [Abstract] [Full Text] [Related]

  • 25. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH, Gaglia MA, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):491-5. PubMed ID: 19195508
    [Abstract] [Full Text] [Related]

  • 26. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2029-36. PubMed ID: 18021868
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
    Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.
    Chin Med J (Engl); 2009 Mar 20; 122(6):643-7. PubMed ID: 19323927
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group.
    Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051
    [Abstract] [Full Text] [Related]

  • 34. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
    Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I, Weisz G, Kreps EM, Collins M, Frankin-Bond T, Stone GW, Moses JW, Leon MB, Mehran R.
    Am J Cardiol; 2008 Jan 01; 101(1):58-62. PubMed ID: 18157966
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE, Melbourne Interventional Group.
    Am J Cardiol; 2008 Jun 15; 101(12):1716-22. PubMed ID: 18549846
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L.
    Circulation; 2008 Nov 25; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [Abstract] [Full Text] [Related]

  • 40. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.
    Garg P, Cohen DJ, Gaziano T, Mauri L.
    J Am Coll Cardiol; 2008 May 13; 51(19):1844-53. PubMed ID: 18466798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.